Fluoxetine for multiple sclerosis

Reza Hosseini; Masih Tajdini; Amirhossein Modabbernia; Shahin Akhondzadeh; Abbas Tafakhori

doi:10.1002/14651858.CD009866.pub2

Fluoxetine for multiple sclerosis

Reza Hosseini
, Masih Tajdini
, Amirhossein Modabbernia
, Shahin Akhondzadeh
, Abbas Tafakhori

Research output: Contribution to journal › Article › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis.

Original language	English
Article number	CD009866
Journal	Cochrane Database of Systematic Reviews
Volume	2018
Issue number	9
DOIs	https://doi.org/10.1002/14651858.CD009866.pub2
State	Published - 5 Sep 2018
Externally published	Yes

Access to Document

10.1002/14651858.CD009866.pub2

Cite this

@article{1981b2fd274a4963aa5941f7da8e00b2,

title = "Fluoxetine for multiple sclerosis",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis.",

author = "Reza Hosseini and Masih Tajdini and Amirhossein Modabbernia and Shahin Akhondzadeh and Abbas Tafakhori",

note = "Publisher Copyright: {\textcopyright} 2018 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2018",

month = sep,

day = "5",

doi = "10.1002/14651858.CD009866.pub2",

language = "English",

volume = "2018",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Fluoxetine for multiple sclerosis

AU - Hosseini, Reza

AU - Tajdini, Masih

AU - Modabbernia, Amirhossein

AU - Akhondzadeh, Shahin

AU - Tafakhori, Abbas

PY - 2018/9/5

Y1 - 2018/9/5

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis.

UR - https://www.scopus.com/pages/publications/85054682102

U2 - 10.1002/14651858.CD009866.pub2

DO - 10.1002/14651858.CD009866.pub2

M3 - Article

AN - SCOPUS:85054682102

SN - 1465-1858

VL - 2018

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD009866

ER -

Fluoxetine for multiple sclerosis

Abstract

Access to Document

Fingerprint

Cite this